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Background
Blood Oxygen Level Dependent (BOLD) magnetic reso-
nance (MR) is a novel imaging tool that is able to detect
tissue oxygenation and has recently been utilized to
evaluate renal function in patients with renal artery ste-
nosis (RAS). Renal BOLD imaging is typically performed
before and after a furosemide stimulus to assess kidney
viability. Furosemide blocks the sodium-potassium-
2chloride transporter, an oxygen-dependent process, in
the ascending loop of Henle located in the renal
medulla. Presumably, kidneys that are able to decrease
oxygen consumption and increase BOLD (T2*) signal in
response to furosemide would be viable and benefit
from revascularization procedures. A standard dose of
20mg of intravenous (IV) furosemide is administered to
evaluate renal responsiveness (increased T2* signal
intensity) and viability. However, little is known about
the effect of prior exposure to furosemide on the ability
of BOLD MR techniques to evaluate renal function.
Methods
We performed comprehensive MR evaluations of renal
artery blood flow with phase contrast angiography and
renal oxygenation with BOLD MR (1.5T Siemens
Avanto) on 54 patients referred for abnormal renal
arterial Doppler exams. We measured BOLD signal
intensity (T2*) in the renal cortex and medulla before
and after 20mg IV furosemide administration as per pre-
viously published studies. Renal function was assessed
by the CKD-EPI glomerular filtration rate (GFR) calcula-
tion. Participants that take furosemide chronically
abstained the morning of the MR scan.
Results
Our study included participants with a wide range of
GFR (21-136 ml/min per 1.73m2, mean 55 ± 26) and
age (46-88 years, mean 69 ± 9). 54% were women, 32%
were African American and 68% Caucasian, and 37%
were diabetic. Home furosemide dose ranged from 0
mg/day to 160 mg/day. 60% of patients evaluated were
furosemide naïve. After controlling for age, GFR, gender,
race, renal artery stenosis (%), and body mass index we
evaluated participants’ home doses of furosemide to
determine if people who are chronically administered
furosemide exhibit similar changes in tissue oxygenation
as those who do not receive chronic furosemide therapy.
Home furosemide dose was an independent, negative
predictor of renal medullary T2* response (p=0.011) in
response to a standard 20mg IV furosemide challenge.
Conclusions
These data suggest that patients who are chronically
administered loop diuretics, especially those receiving
large daily doses (≥ 100mg/daily), may need a different
dosing strategy to accurately detect changes in renal
oxygenation in response to a furosemide stimulus with
BOLD MR. These findings are particularly important in
this patient population because patients who are chroni-
cally administered furosemide (common in patients with
RAS) may be misclassified as having nonviable kidneys1Cardiology, Wake Forest School of Medicine, Winston-Salem, NC, USA
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due to an attenuated T2* signal intensity increases
assessed with BOLD MR.
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Table 1 In a study of 54 patients evaluated for renal
artery stenosis by BOLD MRI before and after furosemide
administration, only race and total daily dose of lasix
were independent predictors of changes in renal
oxygenation.
Effect Estimate Standard Error p-value
Intercept 4.8 2.1 0.57
Region Cortex -4.3 2.2 0.063
Kidney Left 0.68 2.7 0.81
Gender Men -2.0 2.9 0.95
Race AA 7.2 3.21 0.038
Age (years) 0.067 0.23 0.77
GFR (ml/min/ 1.73m2) -0.014 0.062 0.83
Stenosis (%) -0.087 0.062 0.076
BMI (kg/m2) 0.060 0.23 0.80
Lasix dose (mg/day) -0.087 0.03 0.011
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